GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pacira BioSciences Inc (FRA:82P) » Definitions » 12-1 Month Momentum %

Pacira BioSciences (FRA:82P) 12-1 Month Momentum % : -33.85% (As of May. 08, 2024)


View and export this data going back to . Start your Free Trial

What is Pacira BioSciences 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-08), Pacira BioSciences's 12-1 Month Momentum % is -33.85%.

The industry rank for Pacira BioSciences's 12-1 Month Momentum % or its related term are showing as below:

FRA:82P's 12-1 Month Momentum % is ranked worse than
78.82% of 1114 companies
in the Drug Manufacturers industry
Industry Median: -7.25 vs FRA:82P: -33.85

Competitive Comparison of Pacira BioSciences's 12-1 Month Momentum %

For the Drug Manufacturers - Specialty & Generic subindustry, Pacira BioSciences's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pacira BioSciences's 12-1 Month Momentum % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pacira BioSciences's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Pacira BioSciences's 12-1 Month Momentum % falls into.



Pacira BioSciences  (FRA:82P) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pacira BioSciences  (FRA:82P) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Pacira BioSciences 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Pacira BioSciences's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Pacira BioSciences (FRA:82P) Business Description

Traded in Other Exchanges
Address
5401 West Kennedy Boulevard, Suite 890, Tampa, FL, USA, 33609
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has launched EXPAREL which utilizes DepoFoam, a product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time.

Pacira BioSciences (FRA:82P) Headlines

No Headlines